Safety Study of Galantamine in Tic Disorders

Stopped early · Phase 4

Conditions studied: Tourette's Syndrome, Motor Tic Disorder, Vocal Tic Disorder

In brief

The purpose of this study is to determine the safety, tolerability and efficacy of galantamine in tic disorders. The impact of galantamine on commonly associated behaviors (i.e. attention, obsessions, etc.) will also be examined.

Key facts

Study ID
NCT00226824
Run by
Parkinson's Disease and Movement Disorders Center
People needed
1
Starts
2005-09-01
Expected to finish
2007-05-01
Last updated by the study team
2009-08-25

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.